Browse All

Current Filters

CLEAR FILTER x

TITLE

Biomarkers of Inflammation and Neuronal and Glial Injury in Neurosarcoidosis: A Prospective, Observational Pilot Study

Author:Crane, Paul   Mizenko, Christopher   Borko, Tyler   Selva, Sean   Ritchie, Alanna   Eggmann, Sadie   Sillau, Stefan   Piquet, Amanda   

Session Name:P8: Autoimmune Neurology: Neuro-rheumatology and Neurosarcoidosis  

Topic:Autoimmune Neurology  

Program Number:P8.001  

Author Institution:University of Colorado, West Jordan, UT  University of Colorado, Aurora, CO  

Outcome Comparison of Antibiotics-only Versus Antibiotics and Surgical Drainage in Brain Abscesses

Author:Cronin, Jamie   Ung, Timothy   Piquet, Amanda   Money, Kelli   

Session Name:P8: Infectious Disease: Bacterial Infections 2  

Topic:Infectious Disease  

Program Number:P8.002  

Author Institution:University of Colorado, Aurora, CO  University of Colorado, Colorado Springs, CO  

Blood-based Biomarkers of Neuronal and Glial Damage in Active Major Neuropsychiatric Systemic Lupus Erythematosus

Author:Kammeyer, Ryan   Chapman, Kimberly   Furniss, Anna   Ogbu, Ekemini   Nair, Kavita   Borko, Tyler   Fuhlbrigge, Robert   Bennett, Jeffrey   Boackle, Susan   Hsieh, Elena   Zell, Joann   Cooper, Jennifer   Piquet, Amanda   

Session Name:P8: Autoimmune Neurology: Neuro-rheumatology and Neurosarcoidosis  

Topic:Autoimmune Neurology  

Program Number:P8.012  

Author Institution:University of Colorado School of Medicine, Aurora, CO  University of Cincinnati College of Medicine, Aurora, CO  University of Colorado, Aurora, CO  

Earlier Initiation of Ublituximab Treatment Is Associated with Improved Disability Outcomes Among Treatment Naïve Participants in ULTIMATE I and II

Author:Robertson, Derrick   Hartung, Hans-Peter   Qian, Peiqing   Wray, Sibyl   Lee, Lily   Mok, Koby   Garner, Christopher   Alvarez, Enrique   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.001  

Author Institution:University of South Florida, Tampa, FL  Heinrich Heine University Medical Faculty , Dusseldorf, Germany  Swedish Medical Center, Seattle, WA  Hope Neurology, Knoxville, TN  TG Therapeutics, New York, NY  TG Therapeutics, Seal Beach, CA  University of Colorado, Aurora, CO  

Ocrelizumab in Patients With Early-stage RRMS—Results from the Phase IIIb ENSEMBLE Trial and the Matched Real-world NTD MS Registry Cohort

Author:Hartung, Hans-Peter   Holmoy, Trygve   Wuerfel, Jens   Heer, Yanic   Braune, Stefan   Bergmann, Arnfin   Zuercher, Mel   Guye, Sabrina   Kuenzel, Thomas   Moore, Suzanne   Vollmer, Timothy   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.005  

Author Institution:Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University, Dusseldorf, Germany  Akershus University Hospital, Nordbyhagen, Norway  Roche PDMA Neuroscience, Basel, Switzerland  PricewaterhouseCoopers AG, Zurich, Switzerland  NeuroTransData, Neuburg an der Donau, Germany  F. Hoffmann-La Roche Ltd., Basel, Switzerland  University of Colorado, Aurora, CO